Cargando…
Pharmacokinetics and Molecular Modeling Indicate nAChRα4-Derived Peptide HAEE Goes through the Blood–Brain Barrier
One of the treatment strategies for Alzheimer’s disease (AD) is based on the use of pharmacological agents capable of binding to beta-amyloid (Aβ) and blocking its aggregation in the brain. Previously, we found that intravenous administration of the synthetic tetrapeptide Acetyl-His-Ala-Glu-Glu-Amid...
Autores principales: | Zolotarev, Yurii A., Mitkevich, Vladimir A., Shram, Stanislav I., Adzhubei, Alexei A., Tolstova, Anna P., Talibov, Oleg B., Dadayan, Alexander K., Myasoyedov, Nikolai F., Makarov, Alexander A., Kozin, Sergey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234734/ https://www.ncbi.nlm.nih.gov/pubmed/34207317 http://dx.doi.org/10.3390/biom11060909 |
Ejemplares similares
-
Tetrapeptide Ac-HAEE-NH(2) Protects α4β2 nAChR from Inhibition by Aβ
por: Barykin, Evgeny P., et al.
Publicado: (2020) -
Zn-dependent β-amyloid Aggregation and its Reversal by the Tetrapeptide HAEE
por: Mitkevich, Vladimir A, et al.
Publicado: (2023) -
Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor
por: Tolstova, Anna P., et al.
Publicado: (2022) -
Interaction Interface of Aβ(42) with Human Na,K-ATPase Studied by MD and ITC and Inhibitor Screening by MD
por: Adzhubei, Alexei A., et al.
Publicado: (2022) -
Zinc Induced Aβ(16) Aggregation Modeled by Molecular Dynamics
por: Tolstova, Anna P., et al.
Publicado: (2021)